Terms of Reference

The Government's administration of the Pharmaceutical Benefits Scheme (PBS)

Terms of Reference

On 23 June 2011 the Senate referred the following matter to the Finance and Public Administration References Committee for inquiry and report by 18 August 2011:

The Government's administration of the Pharmaceutical Benefits Scheme (PBS), with particular reference to:

(a) the deferral of listing medicines on the PBS that have been recommended by the Pharmaceutical Benefits Advisory Committee;

(b) any consequences for patients of such deferrals;

(c) any consequences for the pharmaceutical sector of such deferrals;

(d) any impacts on the future availability of medicines in the Australian market  due to such deferrals;

(e) the criteria and advice used to determine medicines to be deferred;

(f) the financial impact on the Commonwealth Budget of deferring the listing of medicines;

(g) the consultation process prior to a deferral;

(h) compliance with the intent of the Memorandum of Understanding signed with Medicines Australia in May 2010; and

(i) any other related matter.

For further information, contact:

Senate Finance and Public Administration Committees
PO Box 6100
Parliament House
Canberra ACT 2600

Phone:+61 2 6277 3439
Fax:+61 2 6277 5809